In a patient with a 4 cm type B2 thymoma staged pathologically as pT1b N0 (Masaoka stage I) after complete resection, is adjuvant radiotherapy indicated?

Adjuvant Radiotherapy is NOT Routinely Indicated for pT1bN0 Type B2 Thymoma After Complete Resection

For a completely resected pT1bN0 (Masaoka stage I) type B2 thymoma, adjuvant radiotherapy is not routinely recommended, though it may be considered given the aggressive B2 histology. 1

Clinical Reasoning

Stage Classification is Critical

Your patient has pT1bN0 disease, which corresponds to Masaoka-Koga stage I thymoma (tumor confined to thymus with or without microscopic transcapsular extension). The 4 cm size places this in the T1b category, but it remains stage I disease without capsular invasion or nodal involvement.

Guideline-Based Approach

The ESMO guidelines explicitly state that postoperative radiotherapy is not indicated after complete resection of Masaoka-Koga stage I thymoma 1. This is a Level II evidence recommendation with grade E (not recommended).

However, there's an important nuance: The same guidelines note that for stage II disease, PORT may be considered specifically for aggressive histology (type B2, B3) 1. Your patient sits at the intersection—stage I disease but with B2 histology.

The B2 Histology Factor

Type B2 thymomas are considered more aggressive with higher recurrence potential. The guidelines acknowledge this by suggesting PORT consideration for B2/B3 histology in stage II disease 1. The 2022 Ontario guideline similarly does not routinely recommend PORT for T1bN0 disease, noting that while these patients were categorized as stage III in older studies, negative surgical margins can generally be achieved 2.

Critical Decision Points

You must verify:

• Completeness of resection (R0 vs R1/R2): If margins are positive or close (<1mm), PORT becomes strongly indicated regardless of stage 1
• Actual capsular invasion: Confirm this is truly stage I without capsular penetration. If there's transcapsular invasion (stage IIB), PORT should be considered 1
• Surgical pathology review: Ensure adequate sampling was performed, especially at margins 1

Practical Recommendation

For R0 resection with clear margins (>1mm):

• Observation is appropriate as the standard approach
• Discuss with the patient that B2 histology carries slightly higher risk, but stage I disease has excellent outcomes with surgery alone
• Close surveillance is essential given B2 histology

Consider PORT if:

• Margins are close (<1mm) or positive (R1/R2 resection) 1
• Any evidence of capsular invasion was missed on initial staging
• Patient preference after informed discussion of marginal benefit versus long-term radiation toxicity risks (cardiac disease, secondary malignancies) 3, 2

If PORT is given, use 45-50 Gy with 3D conformal or IMRT techniques to the tumor bed, starting within 3 months of surgery 1.

Common Pitfalls to Avoid

• Don't automatically equate B2 histology with need for PORT in stage I disease—the stage takes precedence over histology in this scenario
• Don't overlook margin status—this is the most critical factor that would change the recommendation
• Don't forget long-term toxicity considerations—radiation carries real risks of cardiac disease and secondary malignancies, particularly relevant in younger patients 3, 2
• Ensure proper pathologic staging—confirm adequate tissue sampling and that no capsular invasion was present 1

The evidence consistently shows stage I thymomas have excellent outcomes with complete resection alone, with 5-year survival exceeding 90% 4. The aggressive histology creates uncertainty, but absent other high-risk features (positive margins, capsular invasion), observation remains the evidence-based standard.